6 Meridian’s Surmodics SRDX Stock Holding History

6 Meridian’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,871	Closed	-$215K	–	424
2021 Q3	$215K	Buy	+3,871	New	+$215K	0.02%	300

Other funds holding SRDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

6 Meridian's SRDX Position: Q4 2021 in Review

6 Meridian sold out of Surmodics (SRDX) in Q4 2021, closing a stake of 3,871 shares — an estimated $215K sold.

6 Meridian first reported a position in SRDX in Q3 2021 and held it in 1 quarter. The position peaked at $215K in Q3 2021. 148 funds tracked by Wall St. Rank hold SRDX as of Q4 2021.

6 Meridian reported no remaining Surmodics position as of Q4 2021 after selling out during the quarter.
6 Meridian sold 3,871 Surmodics shares in Q4 2021, an estimated $215K.
6 Meridian first reported a position in Surmodics in Q3 2021 and held it in 1 quarter.
6 Meridian's Surmodics position peaked at $215K in Q3 2021.
148 funds tracked by Wall St. Rank held Surmodics as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.